Article Text

PDF
Impaired left ventricular energy metabolism in patients with hypertrophic cardiomyopathy is related to the extension of fibrosis at delayed gadolinium-enhanced magnetic resonance imaging
  1. A Esposito1,4,
  2. F De Cobelli1,4,
  3. G Perseghin2,3,4,
  4. M Pieroni5,
  5. E Belloni1,4,
  6. R Mellone1,
  7. T Canu1,4,
  8. F Gentinetta1,
  9. P Scifo4,
  10. C Chimenti6,
  11. A Frustaci6,
  12. L Luzi2,3,
  13. A Maseri7,
  14. A Del Maschio1,4
  1. 1
    Department of Radiology, San Raffaele Scientific Institute and Vita Salute San Raffaele University, Milan, Italy
  2. 2
    Internal Medicine-Section of Nutrition/Metabolism, San Raffaele Scientific Institute, Milan, Italy
  3. 3
    Center of Physical Exercise For Health And Wellness, CDI Faculty of Exercise Sciences, Università degli Studi di Milano, Milan, Italy
  4. 4
    Unit of Clinical Spectroscopy, San Raffaele Scientific Institute, Milan, Italy
  5. 5
    Cardiology Department, Catholic University of the Sacred Heart, Rome, Italy
  6. 6
    Department of Heart and Great Vessels “Attilio Reale,” La Sapienza University Rome, Rome, Italy
  7. 7
    Cardio-Thoracic and Vascular Department, San Raffaele Scientific Institute and Vita-Salute San Raffaele University, Milan, Italy
  1. Dr Antonio Esposito, San Raffaele Scientific Institute, Vita Salute San Raffaele University, Via Olgettina 60, 20132, Milan, Italy; esposito.antonio{at}hsr.it

Abstract

Objective: Areas of intramyocardial late enhancement (LE) at delayed enhanced magnetic resonance imaging (DE-MRI) and reduction of myocardial phosphocreatine (PCr)/ATP-ratio at phosphorus magnetic resonance spectroscopy (31P-MRS) are both reported in hypertrophic cardiomyopathy (HCM) and indicate areas of increased interstitial myocardial space with fibrosis and impairment of myocardial energy metabolism, respectively. We sought to ascertain whether in HCM patients the abnormal features of left ventricular (LV) interstitial space revealed by DE-MRI correlated with impaired LV energy metabolism shown at 31P-MRS.

Methods: 19 patients with HCM proved by histological analysis of multiple endomyocardial biopsies and with normal coronary arteries, underwent cardiac MRI including DE-MRI and 31P-MRS. DE-MRI for detection and quantification of late enhancement (LE) and 31P-MRS to assess the myocardial PCr/ATP-ratio were performed by means of a 1.5-T magnet. 19 healthy subjects, matched for gender and age were studied by 31P-MRS as control group.

Results: LE areas in the LV wall were found in 17 out of 19 patients with an extension ranging from 0.8% to 19.5% of the LV-mass (mean value 7.6% (SD 5.6%). The PCr/ATP-ratio was lower in HCM patients than in control subjects (2.18 (0.41) vs 2.41 (0.30); p<0.05). LE% and PCr/ATP-ratio were inversely related (R = −0.57; p<0.05) and LE% was the stronger predictor of PCr/ATP-ratio by multivariate analysis.

Conclusions: This study demonstrated that the known alteration of the PCr/ATP-ratio observed in HCM patients is correlated with the presence of fibrotic areas in the myocardium of the left ventricle.

Statistics from Altmetric.com

Footnotes

  • Funding: None.

  • Competing interests: None.

  • Ethics approval: Ethics committee approved obtained.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.